Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 91.58% vs 985.71% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is 31.20% vs -5.43% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 42.36% vs 6.47% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is 60.76% vs 0.00% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Compare Quarterly Results Of Syndax Pharmaceuticals, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is 12.17% vs -5.53% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 91.58% vs 985.71% in Jun 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -15.69% vs 37.21% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 31.20% vs -5.43% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is -16.96% vs 45.28% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 42.36% vs 6.47% in Jun 2025
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is 7.63% vs 22.92% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 60.76% vs 0.00% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025






